High-dose ascorbate in combination with anti-pd1 checkpoint inhibition as treatment option for malignant melanoma

HIGHLIGHTS

• who: Markus Burkard et al. from the Department of Nutritional Biochemistry, Institute of Nutritional Sciences, University of Hohenheim, Garbenstrau00dfe, Stuttgart, Germany have published the Article: High-Dose Ascorbate in Combination with Anti-PD1 Checkpoint Inhibition as Treatment Option for Malignant Melanoma, in the Journal: Cells 2023, 12, x FOR PEER REVIEW of 19/Oct/2022
• what: Our data support the benefits of this dual treatment of immunotherapy with highly dosed ascorbate to target melanoma cells.
• how: The authors evaluated high-dose ascorbate for the treatment of the B16F10 melanoma model. The authors evaluated . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.